Evaluating an investigational study drug to see if it may safely and effectively reduce symptoms of moderate to severe lupus in adults. If you are still having lupus symptoms even with medication, you may be eligible to participate in this study. You will be allowed to continue your current lupus medication.
View Trial PageAbout These Research Studies
The REGINA Clinical Trial program includes studies that are testing an investigational medication in people with certain autoimmune disorders to see if it is safe and effective compared to a placebo. The same investigational study drug will be tested in all of the REGINA research studies.
Learn About the Different Studies
If you are interested in learning more about the REGINA Studies, please click on the appropriate link below:
Evaluating an investigational study drug to see if it may safely and effectively reduce symptoms of vitiligo in adults.
Completed EnrollmentFrequently Asked Questions
About the REGINA Studies
The REGINA Studies are being conducted to test an investigational study drug in adults aged 18 to 75. These research studies will evaluate whether the investigational study drug may safely and effectively reduce symptoms.
Before you agree to participate, the study team will review all aspects of the research study with you. If you decide to take part, you will be given a document called an Informed Consent Form that provides, in writing, the research study’s purpose, assessments, procedures, potential benefits and risks, and precautions. You will have the opportunity to ask questions and decide if participating is right for you.
A placebo looks like the investigational study drug but does not contain any active medicine. Some research studies have a placebo and some do not. All of the REGINA studies will have a placebo. The study doctor will give you more information depending on which research study is the best fit for you.
Privacy, Stopping Participation, Costs, and Permission
The study team respects and protects your privacy and will not share your information except as required by law and will store your personal information with codes that do not identify you. The Informed Consent Form (completed by you prior to participation) will provide more information about how your privacy will be maintained.
Yes, your participation in the research study is entirely voluntary and you may withdraw for any reason, at any time. If you do decide to withdraw early, you will be asked to notify the study team before doing so. You will also be asked to return to the study site at least once to complete a final visit and return any unused study drugs.
No, you will receive the study drugs at no cost. You will also get all study-related medical tests at no cost.
No, your doctor does not have to give permission for you to participate. However, either you or the study doctor, with your permission, may contact your personal doctor to discuss your participation before you begin and keep your doctor up to date about your progress.
About Research Studies
A research study, also known as a clinical trial, tries to answer questions about how medicines work in the people who take them. Researchers run studies to test whether an investigational study drug is safe and effective. These research studies may help doctors find new ways to help prevent, detect, or treat health problems.
Participant safety is the priority. There are rules in place to help protect the rights, safety, and well-being of people who volunteer for research studies. These rules are put in place to make sure research studies follow strict scientific and ethical guidelines.
Before a research study can begin, a review board or ethics committee must review the research study. In the US, this group is called an IRB or Institutional Review Board. An IRB is made up of doctors, scientists, and other members of the community.
Only people who meet all eligibility criteria for a research study may take part. The study team at the site you select will review your medical history and current medical status against the eligibility criteria. They will determine whether you are eligible to participate. You may also be asked to provide information from your medical records to help the study team determine whether you may be eligible.
An investigational study drug is a drug that hasn’t yet been approved for use in the general public. In order to be approved, the investigational study drug must be tested in research studies to see if it is safe and effective for treating the target disease in certain groups of people.
If you are eligible and choose to participate, the study staff will be available to answer any questions you may have.
For more answers to your questions visit: https://www.merckclinicaltrials.com/faq/
What Can You Do Next?
If you think this research study might be a good fit and you are interested in taking part, take the next step to see if you are eligible. The study doctor will help determine which research study is the best fit for you.
Discuss with your doctor or care team
Print this page with details about the trial or email it to your doctor to discuss the clinical trial during your next visit.
Taking part in a clinical trial is an important decision
If you are considering joining a clinical trial, first learn as much as you can about:
- The investigational treatment that is being studied
- What the possible risks and benefits are for participants
Talk to your doctor about the clinical trial before you decide to join.
Read our “What to Consider” page for more questions to ask and think about